Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the protocol is to assess the initial pharmacokinetic (PK) profile of a single
oral dose of GSI-953 to healthy male Japanese subjects and healthy elderly male Japanese
subjects.